Memorial Sloan Kettering Cancer Center

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
MPN
COVID-19
Events

Playback speed

10 seconds

ESMO 2023 Insights: "Durable Efficacy of Zenocutuzumab, a HER2 x HER3 Bispecific Antibody, in Advanced NRG1+ NSCLC"

By Insights from 2023 ESMO Annual Meeting FEATURING Alison Schram

90 views

November 24, 2023

Comments 0

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Lung

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance Systemic Therapy…

2024 ASCO® Annual Meeting Insights Hub

P. Iyengar

80 views

Radiation for Unresectable NSCLC: Where Are We Now and Where Are We …

Memorial Sloan Kettering Cancer Center

D. Gomez

148 views

NSCLC & Targeted Therapy: A Brief Overview and Update in the Metasta…

Memorial Sloan Kettering Cancer Center

M. Hwang

982 views

Advances in Resectable NSCLC

Memorial Sloan Kettering Cancer Center

K. Gray

151 views

ESMO 2023 Insights: "CDC7 Inhibition Constrains Lineage Plasticity a…

Insights from 2023 ESMO Annual Meeting

A. Quintanal-Villalonga

275 views

ESMO 2023 Insights: "Durable Efficacy of Zenocutuzumab, a HER2 x HER…

Insights from 2023 ESMO Annual Meeting

A. Schram

90 views

WCLC 2023 Insights: "MSI and MMR-D Define a Distinct Subset of Lung …

Insights from 2023 WCLC

S. Yang

119 views

Additional Advances in Squamous NSCLC Research and Clinical Trials

i3 Health

M. Kris

110 views

08:03

i3 Health

New Perspectives on Diagnosis and Treatment of EGFR Exon 20 Insertio…

Feat. H. Yu, M. Arcila

2021 ASCO Updates on KEYLYNK-013 Study for Newly Diagnosed LS-SCLC: …

Memorial Sloan Kettering Cancer Center

A. Rimner

252 views

2021 ASCO Updates on METex14 Skipping mNSCLC: ctDNA Dynamics & Resis…

Memorial Sloan Kettering Cancer Center

P. Paik

171 views

Can TTFields with Chemotherapy Improve Clinical Outcome in the First…

Memorial Sloan Kettering Cancer Center

C. Simone II

114 views

Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on A…

Memorial Sloan Kettering Cancer Center

M. Zauderer

266 views

Should We Combine EGFR TKIs With Upfront Radiation Therapy in EGFR+ …

Memorial Sloan Kettering Cancer Center

K. Beal

205 views

Is There a Role for IO in EGFR+ Metastatic Lung Cancer?

GRACE

H. Yu

4.8K views

Current Practice & Challenges in Execution of Genomic Testing in Adv…

Beacon Medical Interchange

J. West, G. Riely

319 views

Should Local Ablation Therapy in Oligometastatic or Oligoprogressing…

Beacon Medical Interchange

J. West, G. Riely

25 views

EGFR Initial Treatment and Acquired Resistance in Advanced NSCLC

GRACE

H. Yu

179 views

Q&A on EGFR Initial Treatment and Acquired Resistance in Advanced NS…

GRACE

H. Yu

33 views

ES-SCLC 2020 Update: Which IO Options Showed Activity in Phase III T…

Nebraska Oncology Society

G. Riely

93 views

Stage IV NSCLC 2020 Update: Is There a Benefit to Short-Course Chemo…

Nebraska Oncology Society

G. Riely

122 views